Dementia Trials Australia (DTAus) is the key body in promoting, facilitating and coordinating both commercially-sponsored and investigator-initiated dementia and cognition trials in Australia. They will hold their Annual Scientific Meeting later this year, with this year’s theme being “The new era in AD therapies”.

ADNeT Director Professor Chris Rowe will be presenting on ADNeT- recruitment and retention in Alzheimer’s clinical trials as well as being part of the Panel Discussion on Hot Topics in Dementia Trials. See the program below.